About this trial
Study Design: A randomized controlled trial with two parallel arms and an allocation ratio of 1:1.
Setting: The study will be conducted in the orthodontic department of Riyadh Elm University hospitals in Riyadh City, Saudi Arabia.
Participants: Patients undergoing fixed or clear aligner orthodontic treatment referred to REU dental hospital will be randomly allocated to either the clear aligner group or the fixed orthodontic appliance group.
Intervention: Prior to orthodontic treatment, all patients will receive phase I periodontal therapy and oral hygiene instructions. Fixed orthodontic appliances will be bonded using metallic brackets with a 0.022-inch slot and 0.014-inch NiTi archwires. Clear aligner patients will receive Invisalign® treatment.
Outcomes and Saliva Collection: Salivary samples will be collected using the spitting method at baseline (T0) and follow-up time points according to the study protocol. Salivary flow rate, pH, and buffering capacity will be assessed as described in the proposal.
Randomization and Blinding: Randomization will be performed using a random number generator with allocation concealment via opaque envelopes. The investigators involved in outcome assessment and data analysis will be blinded.
Ethical Considerations: The study will be submitted to the Institutional Review Board at Riyadh Elm University and conducted in accordance with IRB policies.
Eligibility criteria
Qualifiers
Class I, II and III skeletal malocclusion.
Age ≥18 undergoing fixed or Clear aligner orthodontic treatment.
Disqualifiers
Current medications including antibiotic use within the past 3 months that affect salivary flow and composition.
Active smoking including vaping and E-cigarette use.
Diagnosis of systemic diseases/conditions such as Sjogren's syndrome, diabetes, chronic kidney diseases, neurological conditions.
Active dental caries or signs of gingivitis and/or periodontitis
Trial design
Treatments tested in this trial
- Fixed orthodontic appliances
- Clear Aligner Treatment